Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
Our next meeting will be at 3:00 on October 10th, in room 3160 of the Discovery building. Our Selected paper is Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.
The abstract is as follows.
To provide a detailed analysis of the molecular components and underlying mechanisms associated with ovarian cancer, we performed a comprehensive mass-spectrometry-based proteomic characterization of 174 ovarian tumors previously analyzed by The Cancer Genome Atlas (TCGA), of which 169 were high-grade serous carcinomas (HGSCs). Integrating our proteomic measurements with the genomic data yielded a number of insights into disease, such as how different copy-number alternations influence the proteome, the proteins associated with chromosomal instability, the sets of signaling pathways that diverse genome rearrangements converge on, and the ones most associated with short overall survival. Specific protein acetylations associated with homologous recombination deficiency suggest a potential means for stratifying patients for therapy. In addition to providing a valuable resource, these findings provide a view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC
We welcome all who can join us for this discussion. Feel free to begin that discussion in the comments section below.